AI assistant
Doseology Sciences Inc. — Capital/Financing Update 2026
May 19, 2026
48002_rns_2026-05-19_62033e2a-ad2f-499d-a01d-98dea3a1bb16.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
FORM 51-102F3
MATERIAL CHANGE REPORT
Item 1: Name and Address of Reporting Issuer
Doseology Sciences Inc. (the "Company" or "Doseology")
Suite 305, 9-3151 Lakeshore Rd.
Kelowna, BC V1W 3S9
Item 2: Date of Material Change
April 28, 2026.
Item 3: News Release
A news release was issued May 15, 2026 and filed on SEDAR+ at www.sedarplus.ca.
Item 4: Summary of Material Changes
The Company announced that, further to its news release of March 30, 2026, it has received a 45-day extension from the Canadian Securities Exchange to close its non-brokered private placement (the "Offering"). See item 5 for further details.
Item 5: Full Description of Material Change
The Company announced that further to its news release of March 30, 2026, it has received a 45-day extension from the Canadian Securities Exchange to close its Offering. The Offering will consist of up to 3,225,806 units (each, a "Unit") at a price of $0.62 per Unit to raise aggregate gross proceeds of up to $2,000,000.
Additionally, the Company announced that Tim Corkum has resigned as the Company's President and COO effective April 28, 2026. The Company thanks Mr. Corkum for his contributions to the Company and wishes him well in his future endeavors.
Item 6: Reliance on subsection 7.1(2) or (3) of National Instrument 51-102
Not applicable.
Item 7: Omitted Information
Not applicable.
Item 8: Executive Officer
For further information, please contact:
Chris Jackson, CEO
Email: [email protected]
Phone: 604.908.3095
Item 9: Date of Report
May 15, 2026.